Getting your product into customers’ hands is often an undervalued—and under-engineered—part of your organization’s value chain.

Some are calling it, “The Great Resignation.” Others are calling it “

The pandemic has seen an unprecedented global effort to accelerate the development of safe and effective vaccines as well as a rapid expansion of vaccine manufacturing capacity.

Simulation technology is continually advancing to model increasingly real-world product behavior; however, many companies lag in its adoption.

I just received and read the “2021 ASQE Insights on Excellence Executive Brief.” The brief examines how quality initiatives are progressing in the digital era, based

The RoboCrane—now hard at work at the Chernobyl and Fukushima nuclear cleanup sites—is a good example of a successfully commercialized technology invented at the National Institute of Standards and Technology (NIST). I’ll try to tell that story here.

Employee engagement has been a boardroom buzzword for quite some time. We’ve long known engagement matters. Still, the unspoken “but” has always been that metrics—especially those of the performance and financial ilk—matter more.

Organizations will need to pivot their corporate culture if they wish to survive and thrive in the world of virtual collaboration after the pandemic.

For medical device manufacturers, finding success means setting ourselves up for success with repeatable processes that not only ensure quality but also mitigate future risk.

Risks are inherent in the construction industry, and they come in various types.